[Pharmacopsychiatry and iatrogenic parkinsonism].
D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D003024:Clozapine / Q000009:adverse effects; D006220:Haloperidol / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D011950:Receptors, Cholinergic / Q000187:drug effects; D012890:Sleep / Q000187:drug effects
D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D011950:Receptors, Cholinergic; D003024:Clozapine; D006220:Haloperidol
Farmacopsiquiatría y parkinsonismo yatrogénico.